Search research articles
Contact Us
Filters
Showing results (31-40 of 67) with videos related to
Page
of 7
Sort By:
The American Journal of Pathology
|
April 1, 1993
Multiple tumor types appear in a transgenic mouse with the ras oncogene
R D Cardiff, A Leder, A Kuo, et al.
Cancer Immunology, Immunotherapy : CII
|
January 1, 1987
Natural killer (NK) cell immunodeficiency in patients with chronic myelogenous leukemia. II. Successful cloning and amplification of natural killer cells
Y Fujimiya, W C Chang, A Bakke, et al.
Cell
|
May 23, 1986
Consequences of widespread deregulation of the c-myc gene in transgenic mice: multiple neoplasms and normal development
A Leder, P K Pattengale, A Kuo, et al.
International Journal of Cancer
|
October 15, 1981
Lysis of human B-lymphocyte-derived lymphoma/leukemia cells of established cell lines by interferon-activated natural killer (NK) cells
P K Pattengale, M Gidlund, K Nilsson, et al.
American Journal of Hematology
|
March 1, 1990
Immunogenetic analysis of bone marrow aspirates in patients with non-Hodgkin lymphomas
D J Ellison, E Hu, D Zovich, et al.
European Journal of Immunology
|
November 1, 1983
Natural killer activity in (C57BL/6 X DBA/2)F1 hybrids undergoing acute and chronic graft-vs.-host reaction
P K Pattengale, U Ramstedt, M Gidlund, et al.
Human Gene Therapy
|
September 25, 1999
Combination of CD80 and granulocyte-macrophage colony-stimulating factor coexpression by a leukemia cell vaccine: preclinical studies in a murine model recapitulating Philadelphia chromosome-positive acute lymphoblastic leukemia
R Stripecke, D C Skelton, P K Pattengale, et al.
Nature
|
March 15, 1990
Acute leukaemia in bcr/abl transgenic mice
N Heisterkamp, G Jenster, J ten Hoeve, et al.
Blood
|
December 15, 1995
BCR/ABL P210 and P190 cause distinct leukemia in transgenic mice
J W Voncken, V Kaartinen, P K Pattengale, et al.
International Journal of Cancer
|
January 15, 1982
Lysis of fresh human B-lymphocyte-derived leukemia cells by interferon-activated natural killer (NK) cells
P K Pattengale, M Gidlund, K Nilsson, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 67) with videos related to
Sort By:
Page
of 7
The American Journal of Pathology
|
April 1, 1993
Multiple tumor types appear in a transgenic mouse with the ras oncogene
R D Cardiff, A Leder, A Kuo, et al.
Cancer Immunology, Immunotherapy : CII
|
January 1, 1987
Natural killer (NK) cell immunodeficiency in patients with chronic myelogenous leukemia. II. Successful cloning and amplification of natural killer cells
Y Fujimiya, W C Chang, A Bakke, et al.
Cell
|
May 23, 1986
Consequences of widespread deregulation of the c-myc gene in transgenic mice: multiple neoplasms and normal development
A Leder, P K Pattengale, A Kuo, et al.
International Journal of Cancer
|
October 15, 1981
Lysis of human B-lymphocyte-derived lymphoma/leukemia cells of established cell lines by interferon-activated natural killer (NK) cells
P K Pattengale, M Gidlund, K Nilsson, et al.
American Journal of Hematology
|
March 1, 1990
Immunogenetic analysis of bone marrow aspirates in patients with non-Hodgkin lymphomas
D J Ellison, E Hu, D Zovich, et al.
European Journal of Immunology
|
November 1, 1983
Natural killer activity in (C57BL/6 X DBA/2)F1 hybrids undergoing acute and chronic graft-vs.-host reaction
P K Pattengale, U Ramstedt, M Gidlund, et al.
Human Gene Therapy
|
September 25, 1999
Combination of CD80 and granulocyte-macrophage colony-stimulating factor coexpression by a leukemia cell vaccine: preclinical studies in a murine model recapitulating Philadelphia chromosome-positive acute lymphoblastic leukemia
R Stripecke, D C Skelton, P K Pattengale, et al.
Nature
|
March 15, 1990
Acute leukaemia in bcr/abl transgenic mice
N Heisterkamp, G Jenster, J ten Hoeve, et al.
Blood
|
December 15, 1995
BCR/ABL P210 and P190 cause distinct leukemia in transgenic mice
J W Voncken, V Kaartinen, P K Pattengale, et al.
International Journal of Cancer
|
January 15, 1982
Lysis of fresh human B-lymphocyte-derived leukemia cells by interferon-activated natural killer (NK) cells
P K Pattengale, M Gidlund, K Nilsson, et al.
Page
of 7